Fiscal Year:
2002
Title:
HIV ENVELOPE CELL-ARRAYS
Agency:
HHS
Contract:
1R43GM065755-01
Award Amount:
$101,115.00
Abstract:
ViraCore is a biotechnology company developing a drug discovery tool, the cell-array, that enables scientists in academia and industry to determine the function of thousands of protein
variants simultaneously without the need for prior sequencing or individual
site-directed mutagenesis. We propose here to produce and use a cell-array that
is capable of simultaneously expressing thousands of arrayed HIV Envelope (Env)
proteins within living cells on a 1x3 inch glass slide. Each of the thousands
of Env proteins will contain discrete, defined mutations that can enable
antigenic and functional characterization of the protein. Importantly, each of
the thousands of proteins is expressed in a living cell, thus preserving the
structure and function of this highly complex, oligomeric molecule. We expect
that Phase I will enable us to further develop and validate the tools required
to build cell-arrays for studying Env. In Phase II, we will use the mutant Env
arrays to screen for Env mutants that can serve as better immunogens, that
expose hidden epitopes, that retain structural integrity after exposure to
adverse conditions, that alter their requirements for receptor/coreceptor
activation, and that have altered processing.
Small Business Information at Submission:
INTEGRAL MOLECULAR
INTEGRAL MOLECULAR 3701 MARKET ST, STE 340 PHILADELPHIA, PA 19104
EIN/Tax ID:
233091965
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned:
No
Minority-Owned:
No
HUBZone-Owned:
No